Charles Butler

Charles Butler has served as our Vice President, Investor Relations and Communications since November 2021. Charles has over 20 years of experience in investor relations and communications in the biotechnology sector. Prior to joining IN8bio he spent a number of years as Vice President of Investor Relations at biotechnology and healthcare IT companies including Castlight Health, Adverum Biotechnologies and Eiger Biopharmaceuticals. Most notably, Charles spent 10 years at Exelixis, Inc. where he led all communications from the preclinical through the commercial stage of the company. He was part of the team that raised over $1 billion in capital from the equity markets and business development transactions. Prior to Exelixis, he worked at Ogilvy in New York and London where he was a leader of the team that launched 6+ blockbuster drugs for several pharmaceutical companies. While in London, he managed a 25+ person team that oversaw healthcare communications for the United Kingdom and Europe.

Charles received a B.A. in Political Science from George Washington University.